Skip to search formSkip to main contentSkip to account menu

Myasthenia Gravis

Known as: Myasthenia Gravis [Disease/Finding], myasthenia gravis disorder, myasthenia gravis (MG) 
A disorder of neuromuscular transmission characterized by weakness of cranial and skeletal muscles. Autoantibodies directed against acetylcholine… 
National Institutes of Health

Related topics

Related topics

46 relations
1 ML Atropine Sulfate 1 MG/ML Injection12 HR Hyoscyamine Sulfate 0.375 MG Extended Release Oral Tablet24 HR Oxybutynin chloride 10 MG Extended Release Oral TabletAtropine

Broader (3)

Muscle WeaknessMyastheniasPeripheral Neuropathy

Narrower (1)

Myasthenia Gravis, Ocular

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Myasthenia gravis.
Myasthenia gravis (MG) is an autoimmune disease caused by antibodies against the acetylcholine receptor (AChR), muscle-specific… 
Highly Cited
2016
Highly Cited
2016
Randomized trial of thymectomy in myasthenia gravis.
We appreciate the wide interest in the results from the international extended transsternal thymectomy trial in non-thymomatous… 
Highly Cited
1999
Highly Cited
1999
Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis.
IFN-gamma can either adversely or beneficially affect certain experimental autoimmune diseases. To study the role of IFN-gamma in… 
Highly Cited
1986
Highly Cited
1986
Immunotherapy for myasthenia gravis: a murine model.
In vivo therapy with monoclonal antibody (mAb) GK1.5, which recognizes a glycoprotein antigen designated L3T4 on murine helper T… 
Highly Cited
1986
Highly Cited
1986
Characteristics of monoclonal antibodies to denatured Torpedo and to native calf acetylcholine receptors: Species, subunit and region specificity
Review
1985
Review
1985
Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton syndrome.
The muscular weakness and excessive fatigability that characterize the disease now known as myasthenia gravis (MG) were initially… 
Highly Cited
1983
Highly Cited
1983
Prevention and therapy with electrolectin of experimental autoimmune myasthenia gravis in rabbits
Electrolectin (EL), an endogenous β‐D‐galactoside‐binding lectin from Electrophorus electricus, was found to have a prophylactic… 
Review
1981
Review
1981
The biology of myasthenia gravis.
Myasthenia gravis (MG) is a neuromuscular disorder of man characterized by weakness and fatigability of skeletal muscles. The… 
Highly Cited
1980
Highly Cited
1980
Plasmapheresis therapy in myasthenia gravis
Plasmapheresis in the treatment of myasthenia gravis has led to disparate results when applied by different investigators because… 
Highly Cited
1965
Highly Cited
1965
IMMUNOLOGICAL CONCOMITANTS OF MYASTHENIA GRAVIS
In 1954, prompted by certain clinical observations1" and the findings of other investigators,3.' Nastuk, Strauss, and Osserman… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)